Amgen
AMGN
1,601 hedge funds and large institutions have $95.6B invested in Amgen in 2017 Q1 according to their latest regulatory filings, with 152 funds opening new positions, 680 increasing their positions, 576 reducing their positions, and 71 closing their positions.
114% more first-time investments, than exits
New positions opened: 152 | Existing positions closed: 71
22% more funds holding in top 10
Funds holding in top 10: 65 → 79 (+14)
18% more repeat investments, than reductions
Existing positions increased: 680 | Existing positions reduced: 576
13% more capital invested
Capital invested by funds: $84.9B → $95.6B (+$10.7B)
4% more funds holding
Funds holding: 1,541 → 1,601 (+60)
1.04% more ownership
Funds ownership: 78.1% → 79.14% (+1%)
33% less call options, than puts
Call options by funds: $1.15B | Put options by funds: $1.71B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$7.72B |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.26B |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$592M |
| 4 |
Barclays
London,
United Kingdom
|
+$248M |
| 5 |
Goldman Sachs
New York
|
+$164M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$1.36B |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$392M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$151M |
| 4 |
Primecap Management
Pasadena,
California
|
-$148M |
| 5 |
O
OrbiMed
New York
|
-$148M |
AMGN Hedge Fund Activity: Q1 2017 in Review
1,601 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q1 2017, worth a combined $95.6B — up 13% from $84.9B a quarter earlier.
Buyers outnumbered sellers: 152 funds opened new AMGN positions and 71 closed out — a net gain of 81 holders — while 680 added to existing stakes and 576 trimmed.
The largest buyer was BlackRock, adding an estimated $7.72B. The largest seller was Capital Research Global Investors, cutting an estimated $1.36B.
- 1,601 institutional investors held Amgen (AMGN) as of Q1 2017, up from 1,541 in Q4 2016.
- Funds reported $95.6B of Amgen stock for Q1 2017, up 13% quarter-over-quarter.
- 152 funds opened new Amgen positions in Q1 2017 and 71 closed out, a net change of +81 holders.
- The largest Amgen buyer in Q1 2017 was BlackRock, an estimated $7.72B added.
- The largest Amgen seller in Q1 2017 was Capital Research Global Investors, an estimated $1.36B sold.
Based on aggregated 13F filings for Q1 2017.